“…During each task scan, participants received a single bolus intravenous infusion at 60 seconds while lying in the scanner: either saline or isoproterenol hydrochloride (Valeant Pharmaceuticals, Laval, Quebec, Canada), at a dose of 1 microgram (μg) or 2 μg. We selected these bolus doses because (i) they produced sizeable and reliable changes in cardiorespiratory parameters in our previous studies (Khalsa, et al, 2016; Khalsa, et al, 2009a; Khalsa, et al, 2009b), (ii) we have found them to be well tolerated in the fMRI environment (Hassanpour, et al, 2016), and (iii) they induce transient changes lasting <100 seconds, so that we can expect their effects do not extend to subsequent scans. Each dose was repeated twice for a total of six infusion scans, and the infusion order was randomized and double-blinded (Figure 1).…”